[1] Moutsopoulos NM, Moutsopoulos HM.The oral mucosa: A barrier site participating in tissue-specific and systemic immunity[J]. Oral Dis, 2018, 24(1-2): 22-25. [2] Dawson DV, Drake DR, Hill JR, et al.Organization, barrier function and antimicrobial lipids of the oral mucosa[J]. Int J Cosmet Sci, 2013, 35(3): 220-223. [3] Carpenter GH.The secretion, components, and properties of saliva[J]. Annu Rev Food Sci Technol, 2013, 4: 267-276. [4] Zhang H, Zhang J, Streisand JB.Oral mucosal drug delivery: clinical pharmacokinetics and therapeutic applications[J]. Clin Pharmacokinet, 2002, 41(9): 661-680. [5] 王亚敏, 孟文霞, 周震, 等. 血管生成相关因子在口腔白斑癌变过程中的表达及意义[J]. 实用医学杂志, 2019, 35(8): 1265-1268. [6] 王宇峰, 尚书, 周曾同, 等. 口腔白斑癌变率与癌变时间及其影响因素的回顾分析[J]. 上海口腔医学, 2011, 20(1): 55-61. [7] Petti S.Pooled estimate of world leukoplakia prevalence: a systematic review[J]. Oral Oncol, 2003, 39(8): 770-780. [8] 马芮, 刘耀然, 赵继志. 激光治疗口腔黏膜白斑研究进展[J]. 中国实用口腔科杂志, 2018, 11(7): 444-448. [9] Jackowski J, Jöhren P, Müller AM, et al.Imaging of fibrosis of the oral mucosa by 20 MHz sonography[J]. Dentomaxillofac Radiol, 1999, 28(5): 290-294. [10] Dupare A, Dhole A.Ultrasonographic evaluation of submucosal thickness in oral submucous fibrosis patients: a cross-sectional study[J]. Pol J Radiol, 2018, 83: e280-e288. [11] Salmon B, Le Denmat D.Intraoral ultrasonography: development of a specific high-frequency probe and clinical pilot study[J]. Clin Oral Investig, 2012, 16(2): 643-649. [12] 刘逸群, 朱家安, 李建国, 等. 正常人体颊黏膜的超声探测方法学[J]. 中国超声医学杂志, 2018, 34(10): 946-949. [13] Wu W, Wang Z, Zhou Z.Risk factors associated with malignant transformation in patients with oral leukoplakia in a chinese population: a retrospective study[J]. J Oral Maxillofac Surg, 2019, 77(12): 2483-2493. |